No Data
No Data
Japanese Shares Drop as Investors Seek Safety Amid Middle East Tensions
Nxera Pharma Partners With Shionogi to Market Insomnia Drug QUVIVIQ in Japan
October 1st [Today's investment strategy]
[Fisco Selected Stocks] [Material Stocks] Nexera Pharma <4565> 1226 yen (10/1) Drug discovery venture. Former Sosei Group. Its subsidiary Nexera Pharma Japan has announced the signing of a partnership agreement with Shionogi <4507> regarding the distribution and sales of the insomnia treatment drug "Cubick Tablets" in Japan, and resolved its sales efforts with Mochida Pharmaceutical <4534>. Shionogi will independently conduct distribution and sales activities in Japan. [Emerging Markets]
Mochida Pharmaceutical To Go Ex-Dividend On September 27th, 2024 With 40 JPY Dividend Per Share
September 26th (Japan Standard Time) - $Mochida Pharmaceutical(4534.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 40 JPY dividend
List of conversion stocks [List of conversion stocks for parabolic signals]
Buy conversion stocks list market code stock name closing price SAR TOPIX Prime <1333> Maruhanichiro 3149 2760 <1833> Okumura Group 4630 4190 <1979> Taiki Company 4815 4100 <2264> Morinaga Milk 3351 3096 <2270> Yukijirushi Meg
List of cloud-clearing stocks (weekly) (part 2)
Below is a list of stocks that have broken through the clouds. Exchange Code, Stock Name, Closing Price, Leading Span A, Leading Span B Tokyo Stock Exchange Prime, <4507>, Shionogi & Co., Ltd., 6370, 6991.75, 6612.5 <4534>, Mochida Pharmaceutical Co., Ltd., 3215, 3296.25, 3445 <4551>, Torii Pharmaceutical Co., Ltd., 3450, 3662.5, 3500 <4559>
No Data
No Data